Citations

Citations to this article as recorded by  

• Usefulness of Indian Diabetes Risk Score in Predicting Treatment-Induced Hyperglycemia in Women Undergoing Adjuvant Chemotherapy for Breast Cancer
  Krishna Prasad, Sanath Hegde, Suresh Rao, Rhea Katherine D'souza, Thomas George, Sucharitha Suresh, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2025; 14(01): 004.     CrossRef
• Prognostic Factors for Hyperglycemia in Patients Receiving Chemotherapy
  Jiyeong Kim, Kyung Hee Lim
  Cancer Nursing.2025; 48(2): 112.     CrossRef
• Rethinking corticosteroids use in oncology
  Pierrick Martinez, Jean-Marc Sabatier
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Evaluation of the Efficacy and Safety of Palonosetron + Dexamethasone (1-day) + Fosaprepitant + Olanzapine (2.5 mg) in Patients with Lung Cancer Undergoing Carboplatin-based Chemotherapy
  Yuki Mikame, Yasunari Okuda, Makoto Shinada, Takahiro Saito, Naoto Kobayashi, Takako Yamashita, Masato Nakata, Daichi Arai, Mika Ohira, Izumi Tamura, Yasushi Imai
  Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences).2024; 50(10): 531.     CrossRef
• Dexamethasone-sparing on days 2–4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial)
  Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura, Hitoshi Arioka, Hirotoshi Iihara, Mitsuhiro Sugawara, Hajime Morita, Ayako Mochizuki, Shuichi Nawata, Keisuke Mishima, Ayako Tsuboya, Tempei Miyaji, Kazunori Honda, Ayako Yokomizo, Naoya Hashimoto, Takes
  British Journal of Cancer.2024; 130(2): 224.     CrossRef
• A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I-
  Daiki Tsuji, Shigeru Nakagaki, Itsuki Yonezawa, Kenichi Suzuki, Takashi Yokokawa, Yohei Kawasaki, Takumi Yamaguchi, Takashi Kawaguchi, Masahiro Hatori, Takuma Matsumoto, Yukio Sakata, Keisuke Yamamoto, Tomoyasu Nishimura, Yuki Kogure, Toshinobu Hayashi, M
  Investigational New Drugs.2024; 42(1): 44.     CrossRef
• Change in abdominal obesity after colon cancer surgery – effects of left-sided and right-sided colonic resection
  Younes Kays Mohammed Ali, Troels Gammeltoft Dolin, Janus Damm Nybing, Jakob Lykke, Frederik Hvid Linden, Erik Høgh-Schmidt, Thorkild I. A. Sørensen, Jesper Frank Christensen, Yousef J. W. Nielsen, Jim Stenfatt Larsen, Sten Madsbad, Julia Sidenius Johansen
  International Journal of Obesity.2024; 48(4): 533.     CrossRef
• Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study)
  Venkatraman Radhakrishnan, Kritthivasan Venkatakrishnan, Jayachandran Perumal Kalaiyarasi, Gangothri Selvarajan, Nizamudin Mahaboobasha, Paulson Vijaykumar Victor, Malarvizhi Anbazhagan, Deyva Manohari Sivanandam, Swaminathan Rajaraman
  JCO Global Oncology.2024;[Epub]     CrossRef
• Glucocorticoid-Induced Hyperglycemia: A Neglected Problem
  Jung-Hwan Cho, Sunghwan Suh
  Endocrinology and Metabolism.2024; 39(2): 222.     CrossRef
• The impact of surgery and oncological treatment on risk of type 2 diabetes onset in patients with colorectal cancer: nationwide cohort study in Denmark
  Caroline Krag, Maria Saur Svane, Sten Madsbad, Susanne Boel Graversen, Jesper Frank Christensen, Thorkild IA Sørensen, Louise Lang Lehrskov, Tinne Laurberg
  eLife.2024;[Epub]     CrossRef
• Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Jap
  Ayako Yokomizo, Kazuhisa Nakashima, Arisa Iba, Kenji Okita, Makoto Wada, Keiko Iino, Tatsuo Akechi, Hirotoshi Iihara, Chiyo K. Imamura, Ayako Okuyama, Keiko Ozawa, Yong-Il Kim, Hidenori Sasaki, Eriko Satomi, Masayuki Takeda, Ryuhei Tanaka, Takako Eguchi N
  International Journal of Clinical Oncology.2024; 29(11): 1632.     CrossRef
• Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clin
  Kazuhisa Nakashima, Ayako Yokomizo, Michiyasu Murakami, Kenji Okita, Makoto Wada, Keiko Iino, Tatsuo Akechi, Hirotoshi Iihara, Chiyo K. Imamura, Ayako Okuyama, Keiko Ozawa, Yong-il Kim, Hidenori Sasaki, Eriko Satomi, Masayuki Takeda, Ryuhei Tanaka, Takako
  International Journal of Clinical Oncology.2024; 29(12): 1785.     CrossRef
• Corticosteroid therapy in older adults with cancer: Expert recommendations from a task force of the International Society of Geriatric Oncology
  Rupert Bartsch, Daniel Aletaha, Thorsten Fuereder, Matti Aapro, Francois R. Jornayvaz, Pierre-Olivier Lang, Denis Migliorini, Chantal Csajka, Marie-Bernadette Aretin, Vérène Dougoud-Chauvin
  Journal of Geriatric Oncology.2024; : 102077.     CrossRef
• Diabetes and cancer: Optimising glycaemic control
  Nalinie Joharatnam‐Hogan, Daniel L. Morganstein
  Journal of Human Nutrition and Dietetics.2023; 36(2): 504.     CrossRef
• Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study)
  Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio, Elena Collovà, Federica Bertolini, Fausto Petrelli, Alessandra Cassano, Rita Chiari, Francesca Zanelli, Salvatore Pisconti, Isabella Vittimberga, Antonietta
  Scientific Reports.2023;[Epub]     CrossRef
• Diabetes and cancer co-management: patient-reported challenges, needs, and priorities
  Laura C. Pinheiro, Jacklyn Cho, Julia Rothman, Caroline Zeng, Micayla Wilson, Lisa M. Kern, Rulla M. Tamimi, Monika M. Safford
  Supportive Care in Cancer.2023;[Epub]     CrossRef
• Link between Blood Cell-Associated Inflammatory Indices and Chemotherapy-Induced Hyperglycemia in Women Affected with Breast Cancer: Clinical Studies
  Krishna Prasad, Suresh Rao, Sanath Kumar Hegde, Thomas George, Rhea Katherine D'souza, Sucharitha Suresh, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2023; 12(02): 118.     CrossRef
• Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer
  Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, Niki Tank Patel, Mina Sedrak, Daphne Stewart, James Waisman, Yuan Yuan, Wai Yu, Raynald Samoa, Nora Ruel, Susan E. Yost, Hayley Lee, Sung Hee Kil, Joanne E. Mortimer
  Journal of Clinical Medicine.2023; 12(5): 1906.     CrossRef
• Dexamethasone-free antiemetic strategy for highly emetogenic chemotherapy: safety and efficacy-pilot study
  Vinod Sharma, Akash Kumar, Annie Baa, Sudhir Kirar, Atul Sharma, Sameer Bakhshi, Ajay Gogia, Prabhat Singh Malik, Sameer Rastogi, Atul Batra, Deepam Pushpam, Babita Kataria, Hari Sagiraju, Aparna Sharma, Vishwajeet Singh
  BMJ Supportive & Palliative Care.2023; 13(e3): e867.     CrossRef
• Identifying patients with diabetes in a day‐case systemic anti‐cancer therapy population: the Belfast Regional Oncology Centre experience
  Adam Waterworth, Ashleigh Hamilton, Philip Johnston, Anna Todd, Grainne Connolly, Ailish Nugent, Paula Scullin, Sarah McKenna, Sarah Lawless, Helen Wallace, Ian Wallace
  Practical Diabetes.2023; 40(3): 26.     CrossRef
• Dexamethasone-sparing regimens with NEPA (netupitant/palonosetron) for the prevention of chemotherapy-induced nausea and vomiting in older patients (>65 years) fit for cisplatin: A sub-analysis from a phase 3 study
  Luigi Celio, Rupert Bartsch, Matti Aapro
  Journal of Geriatric Oncology.2023; 14(6): 101537.     CrossRef
• Effects of Vitamin Intake on Blood Glucose in Cancer Patients Undergoing Chemotherapy: Quantitative and Descriptive Research
  Ji Yeong Kim, Kyung Hee Lim
  Korean Journal of Adult Nursing.2023; 35(2): 148.     CrossRef
• Effectiveness of Palonosetron, 1-Day Dexamethasone, and Aprepitant in Patients Undergoing Carboplatin-Based Chemotherapy
  Toshinobu Hayashi, Mototsugu Shimokawa, Koichi Matsuo, Masanobu Uchiyama, Kei Kawada, Takafumi Nakano, Takashi Egawa
  Oncology.2023; 101(9): 584.     CrossRef
• COVID‐19 and dexamethasone‐induced hyperglycaemia: Workload implications for diabetes inpatient teams
  Younes R. Younes, Susan Stockley, Lorna Keegan, Linda O’Donoghue, Elizabeth Yohannan, Liz Read, Jamie‐Leigh Williamson, John Peter, Kavitha Lakshmipathy, Vera Smout, Vidhu Nayyar, Julian Emmanuel, Sunil Zachariah, James Clark, Benjamin C. T. Field
  Diabetic Medicine.2022;[Epub]     CrossRef
• The effectiveness and safety of corticosteroid therapy for IgA nephropathy with crescents: a prospective, randomized, controlled study
  Mengjun Liang, Liping Xiong, Aihua Li, Jiafan Zhou, Yajuan Huang, Miaofang Huang, Xing Zhang, Hongrui Shi, Ning Su, Yi Wei, Zongpei Jiang
  BMC Nephrology.2022;[Epub]     CrossRef
• Insulin resistance and weight gain in women treated for early stage breast cancer
  Grace Makari-Judson, Richard Viskochil, Deborah Katz, Ruth Barham, Wilson C. Mertens
  Breast Cancer Research and Treatment.2022; 194(2): 423.     CrossRef
• Cytoprotective effect of genistein against dexamethasone-induced pancreatic β-cell apoptosis
  Kanchana Suksri, Namoiy Semprasert, Thawornchai Limjindaporn, Pa-thai Yenchitsomanus, Sirirat Kooptiwoot, Suwattanee Kooptiwut
  Scientific Reports.2022;[Epub]     CrossRef
• Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study
  Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio, Elena Collovà, Federica Bertolini, Fausto Petrelli, Alessandra Cassano, Rita Chiari, Francesca Zanelli, Salvatore Pisconti, Isabella Vittimberga, Antonietta
  BMC Cancer.2022;[Epub]     CrossRef
• Efficacy of the Dexamethasone-Sparing Triplet Regimen for Preventing Cisplatin-Induced Emesis: a Combined Analysis
  Luigi Celio, Erminio Bonizzoni, Elena Montani, Matti Aapro
  Future Oncology.2022; 18(30): 3389.     CrossRef
• How should rheumatologists manage glucocorticoid-induced hyperglycemia?
  Hiroyuki Nakamura, Yuichiro Fujieda, Akinobu Nakamura, Tatsuya Atsumi
  Modern Rheumatology.2021; 31(3): 519.     CrossRef
• A single-arm feasibility study of gradual dose de-escalation of antiemetic dexamethasone for older patients receiving chemotherapy
  Koung Jin Suh, Seonghae Yoon, Jin Won Kim, Seo Hyun Yoon, Ji-Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
  Journal of Geriatric Oncology.2021; 12(6): 922.     CrossRef
• Incidence and disease course of new-onset diabetes mellitus in breast and colorectal cancer patients undergoing chemotherapy: A prospective multicenter cohort study
  Eun Kyung Lee, Bokyung Koo, Yul Hwangbo, You Jin Lee, Ji Yeon Baek, Yong Jun Cha, Sun Young Kim, Sung Hoon Sim, Keun Seok Lee, In Hae Park, Hyewon Lee, Jungnam Joo, Sujeong Go, Seung Chul Heo, Min Kyong Moon
  Diabetes Research and Clinical Practice.2021; 174: 108751.     CrossRef
• Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study
  Luigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, Luigi Cavanna, Olga Martelli, Simona Carnio, Elena Collovà, Federica Bertolini, Fausto Petrelli, Alessandra Cassano, Rita Chiari, Francesca Zanelli, Salvatore Pisconti, Isabella Vittimberga, Antonietta
  The Oncologist.2021; 26(10): e1854.     CrossRef
• Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations
  Fei Chen, Lanting Hao, Shiheng Zhu, Xinyuan Yang, Wenhao Shi, Kai Zheng, Tenger Wang, Huiran Chen
  Infectious Diseases and Therapy.2021; 10(4): 1907.     CrossRef
• Glycemic Excursion, Adverse Drug Reactions, and Self-Management in Diabetes Patients Undergoing Chemotherapy: A Literature Review
  Naoko Terao, Kumi Suzuki
  Asia-Pacific Journal of Oncology Nursing.2021; 8(6): 610.     CrossRef
• Patient-Centered Diabetes Care of Cancer Patients
  Anupam Kotwal, Yee-Ming M. Cheung, Grace Cromwell, Andjela Drincic, Houry Leblebjian, Zoe Quandt, Robert J. Rushakoff, Marie E. McDonnell
  Current Diabetes Reports.2021;[Epub]     CrossRef
• Quercetin modulates hyperglycemia by improving the pancreatic antioxidant status and enzymes activities linked with glucose metabolism in type 2 diabetes model of rats: In silico studies of molecular interaction of quercetin with hexokinase and catalase
  Sunday O. Oyedemi, Godswill Nwaogu, Chika I. Chukwuma, Olaoluwa T. Adeyemi, Motlalepula G. Matsabisa, Shasank S. Swain, Olayinka A. Aiyegoro
  Journal of Food Biochemistry.2020;[Epub]     CrossRef
• Side Effects of Adjuvant Chemotherapy and their Impact on Outcome in Elderly Breast Cancer Patients: A Cohort Study
  Valentina Zanuso, Vittorio Fregoni, Lorenzo Gervaso
  Future Science OA.2020;[Epub]     CrossRef
• Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
  Suresh Rao, Krishna Prasad, Soniya Abraham, Thomas George, Supreeth Kakkaje Chandran, Manjeshwar Shrinath Baliga
  South Asian Journal of Cancer.2020; 09(03): 130.     CrossRef
• Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes
  Moein Ala, Razieh Mohammad Jafari, Ahmad Reza Dehpour
  Current Diabetes Reviews.2020; 16(9): 984.     CrossRef
• Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin
  Hiroko Minatogawa, Naoki Izawa, Takashi Kawaguchi, Tempei Miyaji, Kazuhiro Shimomura, Honda Kazunori, Hirotoshi Iihara, Yasushi Ohno, Yusuke Inada, Hitoshi Arioka, Hajime Morita, Naoya Hida, Mitsuhiro Sugawara, Chikatoshi Katada, Shuichi Nawata, Hiroo Ish
  BMJ Open.2020; 10(12): e041737.     CrossRef
• Effect of high-dose dexamethasone on patients without diabetes during elective neurosurgery: a prospective study
  Majid Alabbood, Min Ling, Kenneth Ho
  Diabetology International.2019; 10(2): 109.     CrossRef
• Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma
  Saby George, Brian I. Rini, Hans J. Hammers
  JAMA Oncology.2019; 5(3): 411.     CrossRef
• GLUCOSE EXCHANGE DISORDERS IN PATIENTS TAKING GLUCOCORTICOSTEROIDS: FEATURES OF CLINICAL MANIFESTATIONS AND CORRECTION
  Al’bert Yu. Selimov, Lyudmila N. Eliseeva, Valeriya P. Kurinnaya, Sergei P. Oranskii
  Kuban Scientific Medical Bulletin.2019; 26(1): 209.     CrossRef
• Steroid-induced diabetes in cancer patients
  Gemma Dinn
  Journal of Prescribing Practice.2019; 1(12): 610.     CrossRef
• Hyperglycemia During Childhood Cancer Therapy: Incidence, Implications, and Impact on Outcomes
  Allison Grimes, Ashraf Mohamed, Jenna Sopfe, Rachel Hill, Jane Lynch
  JNCI Monographs.2019; 2019(54): 132.     CrossRef
• Impact of dexamethasone-sparing regimens on delayed nausea caused by moderately or highly emetogenic chemotherapy: a meta-analysis of randomised evidence
  Luigi Celio, Erminio Bonizzoni, Emma Zattarin, Paolo Codega, Filippo de Braud, Matti Aapro
  BMC Cancer.2019;[Epub]     CrossRef
• Placebo-Controlled, Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High-Emetogenic Chemotherapy
  Yuka Ito, Takashi Tsuda, Hiroko Minatogawa, Sayaka Kano, Kentaro Sakamaki, Masahiko Ando, Koichiro Tsugawa, Yasuyuki Kojima, Naoki Furuya, Kunihiro Matsuzaki, Mamoru Fukuda, Sadatoshi Sugae, Ichiro Ohta, Hitoshi Arioka, Yutaka Tokuda, Kazutaka Narui, Ayak
  Journal of Clinical Oncology.2018; 36(10): 1000.     CrossRef
• Glucocorticoid‐induced diabetes among people without diabetes: a literature review
  Majid Alabbood, Min Ling, Kenneth Ho
  Practical Diabetes.2018; 35(2): 63.     CrossRef
• Metformin prevents metabolic side effects during systemic glucocorticoid treatment
  Eleonora Seelig, Stefanie Meyer, Katharina Timper, Nicole Nigro, Martina Bally, Ida Pernicova, Philipp Schuetz, Beat Müller, Marta Korbonits, Mirjam Christ-Crain
  European Journal of Endocrinology.2017; 176(3): 349.     CrossRef
• Central pancreatectomy: an oncologically safe option to treat metastases of other neoplasms of the mid-portion of the pancreas?
  Traian Dumitrascu, Andra Scarlat, Mihnea Ionescu, Irinel Popescu
  Annals of Hepato-Biliary-Pancreatic Surgery.2017; 21(2): 76.     CrossRef
• Outpatient management of steroid-induced hyperglycaemia and steroid-induced diabetes in people with lymphoproliferative disorders treated with intermittent high dose steroids
  Jennifer Vidler, Charlotte Rogers, Deborah Yallop, Stephen Devereux, Ellinor Wellving, Orla Stewart, Alison Cox, Katharine F. Hunt, Shireen Kassam
  Journal of Clinical & Translational Endocrinology.2017; 9: 18.     CrossRef
• Consumption of Fresh Yellow Onion Ameliorates Hyperglycemia and Insulin Resistance in Breast Cancer Patients During Doxorubicin-Based Chemotherapy: A Randomized Controlled Clinical Trial
  Farnaz Jafarpour-Sadegh, Vahid Montazeri, Ali Adili, Ali Esfehani, Mohammad-Reza Rashidi, Saeed Pirouzpanah
  Integrative Cancer Therapies.2017; 16(3): 276.     CrossRef

Citations

Citations to this article as recorded by  

• Glucocorticoid-Induced Hyperglycemia in Oncologic Outpatients: A Narrative Review Using the Quadruple Aim Framework
  Ihab Kandil, Erin Keely
  Canadian Journal of Diabetes.2022; 46(7): 730.     CrossRef
• Association of Comorbid Diabetes With Clinical Outcomes and Healthcare Utilization in Colorectal Cancer Survivors
  Susan Storey, Zuoyi Zhang, Xiao Luo, Diane Von Ah, Megan Metzger, Jie Zhang, Amrutha Jakka, Kun Huang
  Oncology Nursing Forum.2021; 48(2): 195.     CrossRef
• The influence on survival of glucocorticoid induced diabetes in cancer patients with metastatic spinal cord compression
  Helga Schultz, Ulrik Pedersen-Bjergaard, Andreas Kryger Jensen, Svend Aage Engelholm, Peter Lommer Kristensen
  Clinical and Translational Radiation Oncology.2018; 11: 19.     CrossRef
• Measurement of Hyperglycemia and Impact on Health Outcomes in People With Cancer: Challenges and Opportunities
  Susan Storey, Diane Ah, Marilyn Hammer
  Oncology Nursing Forum.2017; 44(4): E141.     CrossRef
• Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors
  Roy E. Strowd, Mackenzie C. Cervenka, Bobbie J. Henry, Eric H. Kossoff, Adam L. Hartman, Jaishri O. Blakeley
  Neuro-Oncology Practice.2015; 2(3): 127.     CrossRef
• The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors
  Roy E. Strowd, Stuart A. Grossman
  Current Treatment Options in Oncology.2015;[Epub]     CrossRef